Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Prostate cancer
Closed
Phase 3
This trial is looking at a new vaccine called PROSTVAC for prostate cancer that has spread.
If prostate cancer has spread outside the prostate gland, doctors often treat it with hormone therapy. This can work very well, but at some stage the cancer may start to grow again. This may not cause symptoms, but your doctor might see changes on a scan or there may be an increase in the level of PSA in your blood.
The immune system can recognise and kill cancer cells. But it is not always very good at doing this. In this trial, researchers are looking at a vaccine called PROSTVAC that can help the immune system to recognise and attack prostate cancer cells.
GM-CSF is a type of growth factor. Growth factors are proteins made in the body and some of them make the bone marrow produce blood cells. GM-CSF makes the body produce white blood cells. The researchers want to find out if giving GM-CSF alongside the vaccine can help it to work better.
The men taking part in this trial have prostate cancer that scans or blood tests show is getting worse. But their cancer is not causing symptoms or only causing very mild symptoms. The researchers will compare men in 3 groups
PROSTVAC alongside GM-CSF
PROSTVAC alongside a dummy drug (placebo)
PROSTVAC dummy drug alongside GM-CSF dummy drug
The aims of the trial are to
See if either PROSTVAC alone or PROSTVAC alongside GM-CSF is better than a dummy drug to help men with prostate cancer live longer
Learn more about the side effects
Recruitment start: 1 November 2011
Recruitment end: 31 December 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Chris Parker
Bavarian Nordic Inc
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 1 August 2016
CRUK internal database number: 12269